The has been absolutely no fundamental change to this bio company that has multiple big pharma partners. Yet due to the overall biotech downturn
PIRS
was hit pretty hard. This presents a true 10 bagger opportunity, and Im not even remotely stretching the truth. The technicals show you why right now is the PERFECT time to buy. A little due diligence will show you why its a must hold in 2016.
As you will find here --> there is plenty in the pipeline, both propietary and partnered. And when your partners are this strong, its hard to fail.
As you will find here --> there is plenty in the pipeline, both propietary and partnered. And when your partners are this strong, its hard to fail.